Lifeboat Foundation

Cupertino calling. Join us for an Apple special event live from the Steve Jobs Theater on September 10 at 10 a.m. PDT. Set a reminder and we’ll send an update before the show.

Revolutionary research is underway to create a cheap, fast, at-home early diagnostic test.

Researchers at Mayo Clinic have identified the enzyme, called CD38, that is responsible for the decrease in nicotinamide adenine dinucleotide (NAD) during aging, a process that is associated with age-related metabolic decline. Results demonstrated an increase in the presence of CD38 with aging in both mice and humans. The results appear today in Cell Metabolism.

“As we age, we experience a decline in our metabolism and metabolic function. This increases the incidence of age-related metabolic diseases like obesity, diabetes and others,” says Eduardo Chini, M.D., Ph.D., anesthesiologist and researcher for Mayo Clinic’s Robert and Arlene Kogod Center on Aging and lead author of the study. “Previous studies have shown that levels of NAD decline during the aging process in several organisms. This decrease in NAD appears to be, at least in part, responsible for age-related metabolic decline.”

In this study, researchers at the Center on Aging have shown that CD38, an enzyme that is present in inflammatory cells, is directly involved in the process that mediates the age-related NAD decline. Comparing 3- to 32-month-old mice, researchers found that levels of CD38 increased at least two to three times during chronological aging in all tissues tested, including the liver, fat, spleen and skeletal muscle.

Researchers at the Universities of Abuja and Nigeria, in collaboration with the University of Bristol, have detected a potentially human-infective microbe in pet dogs in Nigeria.

Dogs in tropical Africa run the risk of contracting canine trypanosomosis if they are bitten by bloodsucking tsetse flies carrying trypanosomes – microscopic, single-celled organisms found in the bloodstream. In dogs, this disease runs a severe course and is often fatal; “white eyes” or corneal cloudiness is one of the characteristic and obvious signs of the disease.

Sick dogs suspected of trypanosomosis are frequently brought to the University of Nigeria Veterinary Teaching Hospital (UNVTH) in Nsukka, where diagnosis relies on examination of a blood smear under the microscope. While trypanosomes are easily detected by their rapid motion among the blood cells, it is hard to determine the exact species of trypanosome by microscopy alone.

Technology entrepreneurs delight in disrupting established industries, from textiles to healthcare to agriculture.

Changes in automotive manufacturing have been tougher to sell because no matter how many computers are put under the hood, the cars themselves “are still being built on 100-year-old concepts,” Daniel Barel, CEO of Israeli automotive startup REE, tells ISRAEL21c.

Continue reading “Israeli startup is totally reinventing how cars are built” »

Breakthroughs in physics sometimes require an assist from the field of mathematics—and vice versa.

Machine learning techniques have so far proved to be very promising for the analysis of data in several fields, with many potential applications. However, researchers have found that applying these methods to quantum physics problems is far more challenging due to the exponential complexity of many-body systems.

Geologists examine what unfolded after that asteroid hit. Richard A Lovett reports.

Dr. David Sinclair, a Professor of Genetics at Harvard Medical School, is one of the most well-known researchers in the field of rejuvenation, and his lab is the beneficiary of a successful Lifespan.io campaign.

Today, Dr. Sinclair is releasing his book on Amazon, “Lifespan: Why We Age and Why We Don’t Have To”, and on Wednesday, September 18, we will be hosting a webinar with Dr. Sinclair as well. Please contact [email protected] if you would like to join or have any questions regarding this webinar.

At International Perspectives in Geroscience, a conference hosted at Weizmann Institute of Science (Israel) on September 4–5, we had the opportunity to interview Dr. Sinclair about his work and his thoughts on the current state of research.